Cargando…
Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale
Current pharmacotherapy of chronic obstructive pulmonary disease (COPD) aims at reducing respiratory symptoms and exacerbation frequency. Effective therapies to reduce disease progression, however, are still lacking. Furthermore, COPD medications showed less favorable effects in emphysema than in ot...
Autores principales: | Janssen, Rob, Wouters, Emiel FM, Janssens, Wim, Daamen, Willeke F, Hagedoorn, Paul, de Wit, Hugo AJM, Serré, Jef, Gayan-Ramirez, Ghislaine, Franssen, Frits ME, Reynaert, Niki L, von der Thüsen, Jan H, Frijlink, Henderik W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884741/ https://www.ncbi.nlm.nih.gov/pubmed/32063701 http://dx.doi.org/10.2147/COPD.S228411 |
Ejemplares similares
-
Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure
por: Franssen, Frits M.E., et al.
Publicado: (2019) -
Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease
por: Franssen, Frits ME, et al.
Publicado: (2011) -
Biomarker-based clustering of patients with chronic obstructive pulmonary disease
por: Vanfleteren, Lowie E.G.W., et al.
Publicado: (2023) -
Skin autofluorescence: early sign of lung function deterioration?
por: Wouters, Emiel F.M., et al.
Publicado: (2020) -
Increased exercise tolerance using daytime mouthpiece ventilation for patients with diaphragm paralysis
por: Koopman, Maud, et al.
Publicado: (2017)